Here’s a bombshell for New York Mets fans: Francisco Lindor, the team’s star shortstop, is headed for surgery on his left hamate bone, a move that could shake up the team’s early-season plans. But here’s where it gets controversial—while the Mets insist Lindor will be ready for Opening Day on March 26, skeptics are already questioning whether rushing his recovery is the smartest move. Let’s break it down.
According to Mets manager Carlos Mendoza, Lindor’s surgery is scheduled for Wednesday to address a stress reaction in the bone. The procedure typically requires a six-week recovery, but Mets president of baseball operations David Stearns remains 'optimistic' about Lindor’s return. And this is the part most people miss—Lindor has been battling soreness in the area for years, yet this is the first time it’s forced him under the knife. Why now? Stearns revealed Lindor’s discomfort flared up after reporting to camp, prompting a visit to a specialist.
With Lindor sidelined, the Mets have several shortstop options for spring training, including Vidal Brujan, Ronny Mauricio, Christian Arroyo, and Jackson Cluff. Here’s the twist—Arroyo and Cluff are non-roster invites, and Mauricio has minimal experience at the position. Could this be an opportunity for Bo Bichette, the newly signed third baseman, to slide back into his old shortstop role? Stearns isn’t ruling it out, but he’s playing it cool: 'If we get to the point where we get closer to Opening Day and there are questions about Francisco, then we’ll cross that bridge when we get there.'
Lindor, who’s in the midst of a six-year, $194.9 million contract, is coming off a stellar 2025 season where he hit .267 with 31 home runs, 31 stolen bases, and 86 RBIs. He’s been a durability machine, playing at least 152 games in each of the last four seasons and avoiding the injured list since 2021. Last season, he even played through a broken pinky toe after being hit by a pitch in June. But the big question remains—is the Mets’ optimism about his Opening Day return justified, or are they risking further injury by rushing his recovery?
This situation raises a thought-provoking debate: Should teams prioritize a player’s long-term health over short-term goals? Let us know your thoughts in the comments—do you think the Mets are making the right call, or are they playing with fire?
